Skip to content
Medical Health Aged Care

New treatment aims to achieve lasting cure for persistent bacterial vaginosis

Monash University and Bayside Health 2 mins read

Researchers and clinicians from Monash University and Bayside Health’s Melbourne Sexual Health Centre are trialing new combinations of antibiotics to treat persistent bacterial vaginosis (BV), following their landmark discovery that the condition is sexually transmissible.

Bacterial vaginosis is the most common vaginal condition among women of reproductive age and is caused by a loss of healthy vaginal bacteria and an overgrowth of other bacteria which upsets the natural balance of the vaginal microbiome.

Researchers from Monash University and Bayside Health’s Melbourne Sexual Health Centre published a landmark study in the New England Journal of Medicine in 2025, showing treating male partners reduces BV recurrence in women by more than 60 per cent.

The discovery reshaped international thinking on the condition and won this year’s Australian Infectious Diseases Research Centre Eureka Prize for Infectious Diseases Research.

Their latest study, published in The Lancet Obstetrics, Gynaecology & Women’s Health, builds on the original finding to reveal why some women continue to experience a repeat diagnosis of BV even when their male partners are treated concurrently, identifying two distinct pathways to repeat infection: re-infection and persistence of BV-bacteria.

Lead author Dr Lenka Vodstrcil, a Senior Research Fellow at Monash University and Bayside Health’s Melbourne Sexual Health Centre, said this has enabled them to work on tailoring treatments that will improve cure rates for millions of women worldwide.

“While partner treatment improves cure for most women in a monogamous relationship, there are some women who have persistent BV-bacteria that survive initial therapy before couples resume sex after treatment,” Dr Vodstrcil said. 

“By identifying this early, we can intervene with more intensive female-focused treatments before the infection takes hold again."

Senior author Vice-Chancellor’s Distinguished Professor Catriona Bradshaw, clinician scientist and Head of Research Translation and Mentorship at Monash University and Bayside Health’s Melbourne Sexual Health Centre, said the new approaches to treatment that are being trialed by her team include longer duration and new combinations of antibiotics designed to eradicate persistent BV-causing bacteria.

“Using partner-treatment to mitigate re-infection and more intensive strategies that target persistence of BV-bacteria, we hope to create more effective treatment approaches that can be tailored to an individual and achieve higher levels of cure for all women,” Professor Bradshaw said.

Read the research paper: https://doi.org/10.1016/S3050-5038(26)00259-1

MEDIA ENQUIRIES 

Toni Brient
Media and Communications Manager
P: +61 423 964 191
E: [email protected]

GENERAL MEDIA ENQUIRIES

Monash Media
P: +61 3 9903 4840
E: [email protected]

For more Monash media stories, visit our news and events site 

More from this category

  • Medical Health Aged Care
  • 18/11/2026
  • 14:20
Dementia Australia

$250,000 in community grants available to support dementia-friendly initiatives across Australia

Dementia Australia is opening applications on Friday 27 November for Community Engagement grants for at least 15 dementia-friendly community initiatives across the country. Dementia Australia CEO Professor Tanya Buchanan said community groups are encouraged to apply for a grant of up to $15,000 for projects that support their local community to become dementia-friendly. "We welcome applications from all community groups, but this year we are particularly encouraging projects focused on diverse communities, including projects led by Aboriginal and Torres Strait Islander people and communities that support people living with dementia and carers,” Professor Buchanan said. “There are an estimated 446,500…

  • Contains:
  • Medical Health Aged Care
  • 18/11/2026
  • 13:00
Royal Australian College of GPs

From AI to health misinformation: Australia’s GPs gather to shape the future of healthcare

Artificial intelligence, health misinformation and improving access to care will be in the spotlight when GPs from across Australia gather in Adelaide for the Royal Australian College of GPs (RACGP) national conference, GP26. The RACGP’s premier annual conference will bring together thousands of GPs, practice team members, health leaders, researchers, policymakers and medical students from across Australia and overseas from 20–22 November 2026 at the Adelaide Convention Centre. Under the theme, “The thriving heart of health”, delegates will share expertise, develop their skills and explore ways to improve patient care through workshops, keynote presentations and panel discussions. Sessions will examine…

  • Contains:
  • Disability, Medical Health Aged Care
  • 18/11/2026
  • 11:57
Vertaview Group

MS Plus partners with Allinto ensuring Support Coordination for participants

Key Facts: Vertaview Group has announced that its subsidiary Allinto will take on the Support Coordination services of MS Plus, with the transfer designed to maintain continuity of care for participants and employment opportunities for staff.Participants will have the option to continue their Support Coordination with Allinto, in most cases retaining their existing Support Coordinator, while MS Plus employees will be offered equivalent roles at Allinto.MS Plus will continue delivering Support Coordination until 4 December 2026, with Allinto taking over from 7 December 2026 for participants who have agreed to the transfer; participants' NDIS plans and budgets will not be…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.